This contract involves the supply of laboratory reagents and the provision of equipment for the Insular Materno Infantil University Hospital Complex. The purpose is to support genetic testing services as part of the Common Services Portfolio of the National Health System, under the Personalized Medi
Contract awarded. Originally published 8 months ago.
No single supplier dominates the field.
In healthcare medical, MANAGEMENT DIRECTORATE OF THE INSULAR MATERNAL AND CHILD UNIVERSITY HOSPITAL COMPLEX has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the procurement of two specific pharmaceutical products: Infliximab and Selumetinib Sulfato. These medications are essential for the Insular-Materno Infantil University Hospital Complex in Gran Canaria, aimed at meeting the hospital's supply needs to treat, alleviate, or cure
This contract involves the procurement of two specific pharmaceutical products, Momelotinib and Sotorasib, to meet the supply needs of the Insular-Materno Infantil University Hospital Complex in Gran Canaria, Spain. The total value of the contract is approximately €200,086.08. Suppliers are invited
This contract opportunity involves the supply, preparation, installation, and commissioning of two digital remote controls. These devices are intended for use at the University Hospital Insular de Gran Canaria and the Telde CAE, both part of the Insular Materno Infantil University Hospital Complex i
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
